Comments: NJ A2830 | 2020-2021 | Regular Session

Bill Title: Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

Sponsorship: Partisan Bill (Democrat 3)

Status: (Introduced - Dead) 2020-02-20 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee [A2830 Detail]

Text: Latest bill text (Introduced) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2020 New Jersey A2830 at this time.

feedback